2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow tipranavir: new trials by email Literature Review of tipranavir trials Research Report on tipranavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours tipranavir/ritonavir (dose reduction) - HIV Infections | Phase 4 | Completed | Germans Trias i Pujol Hospital | 11 | 2007-12-01 | 2019-12-05 |
| HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) Lamivudine, Stavudine, Didanosine - HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease | Phase 4 | Completed | Kirby Institute | 80 | 2003-02-01 | 2012-04-12 |
HIV Infections (2) · Cardiovascular Diseases (1) · HIV-Associated Lipodystrophy Syndrome (1) · Lipodystrophy (1)
Germans Trias i Pujol Hospital (1) · Kirby Institute (1)
Australia (1) · Spain (1)
Andrew D Carr, MD (1) · David A Cooper, MD (1) · Molto Jose, MD,PhD (1)
R01HL065953 (1)